Alta Sciences

AUGUST 29, 2024

Engaging at the outset with a fully integrated and experienced drug development partner can ensure safety, with timely data sharing at every step of the drug development plan, and facilitate agile, flexible decision-making and planning. billion USD in 2023 to $166.53 billion USD by 2028. Image thumbnail-qh33.jpg

Drug Development 52

Drug Development Small Molecule Clinical Trials Drugs 52

Alta Sciences

SEPTEMBER 14, 2023

Dermatology Drug Development Summit lperez Thu, 09/14/2023 - 19:20 Image GettyImages-486143500.jpg jpg Tags Preclinical Research URL [link] Event End Date Thu, 11/02/2023 - 12:00 Event Start Date Tue, 10/31/2023 - 12:00 Weight 5

Drug Development 40

Drug Development Drugs Research 40

KIF1A

SEPTEMBER 30, 2023

Read the Guide FDA Launches Pilot Program to Help Further Accelerate Development of Rare Disease Therapies One frustrating aspect of traditional drug development, especially for rare disease communities, is the tempo of regulatory decisions on potential drugs.

Disease 111

Disease FDA Clinical Trials Therapies 111

Fierce BioTech

OCTOBER 16, 2023

Drug Development Boot Camp® Spring 2024 VIRTUAL The total immersion transformative training will take place VIRTUALLY only, and in real time. jpiatt Mon, 10/16/2023 - 16:30 The total immersion, transformative training will take place at the Harvard Club in Boston. www.drugstomarket.com/drugbootcamp.

Drug Development 52

Drug Development Drugs 52

Alta Sciences

AUGUST 24, 2023

6th Neuropsychiatric Drug Development Summit iianiro Thu, 08/24/2023 - 16:23 Image Boston-4.jpg jpg Synopsis Boston, MA URL [link] Event End Date Thu, 10/12/2023 - 12:00 Event Start Date Tue, 10/10/2023 - 12:00 Weight 1

Drug Development 40

Drug Development Drugs 40

KIF1A

JULY 22, 2023

2023 Scientific findings need to be validated, replicated, and applied to new systems; this is the reason KIF1A.ORG has invested in our Treatment Accelerator Program. Read the Article The post #ScienceSaturday: July 22, 2023 appeared first on KIF1A. ” Chai et al.

Small Molecule 98

Small Molecule FDA Disease Treatment 98

Alta Sciences

AUGUST 29, 2023

Embarking on a Career in Drug Development nbartlett Tue, 08/29/2023 - 14:38 Getting to the Heart of Science with Amber malloy Amber Malloy, Altasciences At the heart of science are stories—stories of courage, challenges, successes, lessons, and people. They remind us of the immense benefits of drug development.

Drug Development 52

Drug Development Analytical Chemistry Drugs Science 52

Alta Sciences

MAY 30, 2023

Altasciences' Proactive Drug Development Solution: Biologics aasimakopoulos Tue, 05/30/2023 - 17:10 Tags Bioanalysis Clinical Trials Preclinical Research Regulatory Affairs Outsourcing Drug Development URL [link] Category eBook

Drug Development 40

Drug Development Clinical Trials Drugs Trials 40

KIF1A

JUNE 3, 2023

2023 This study has a small sample size from a single hospital, and there were patients who did not have available genetic data, so we can’t generalize these statistics too much. This question permeates every step of the drug development process, from testing in cells and animal models to clinical trials and regulatory approval.

FDA 98

FDA FDA Approval Trials Disease 98

SCIENMAG: Medicine & Health

JUNE 27, 2023

HOUSTON – (June 27, 2023) – Many of the drugs we use to treat cancer and infectious disease are ⎯ or derive from ⎯ natural products, but it’s difficult to know exactly how nature assembles them. Credit: (Photo by Gustavo Raskosky/Rice University) HOUSTON – (June 27, 2023) – Many of the drugs we use to […]

Drug Development 77

Drug Development Drugs Disease Production 77

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues. Asia, and Europe.

Drug Development 52

Drug Development Treatment FDA Approval Therapies 52

Alta Sciences

OCTOBER 31, 2023

Accelerated Decision-Making in Drug Development With Altasciences nbartlett Wed, 11/01/2023 - 01:04 Publication Accelerated Decision-Making Infographic One-Pager.pdf Category Infographic Weight 1

Drug Development 40

Drug Development Drugs 40

Alta Sciences

JULY 14, 2023

The Altascientist_E2E CNS Drug Development tchichekian Fri, 07/14/2023 - 15:18 Image Untitled design (25).png png Weight 1

Drug Development 40

Drug Development Drugs 40

Alta Sciences

NOVEMBER 9, 2023

Streamlining Clinical Trial Start-up for Accelerated Drug Development mecabana Thu, 11/09/2023 - 16:54 Publication StreamliningClinicalTrialStart-up-ReducedTimelines.pdf Category Case Study Weight 5

Clinical Trials 40

Clinical Trials Drug Development Trials Drugs 40

Alta Sciences

AUGUST 18, 2023

Symposium in Cambridge, UK—Drug Development in the Current Climate iianiro Fri, 08/18/2023 - 20:01 Image Copy of Untitled Design (5).png Symposium in Cambridge, UK—Drug Development in the Current Climate iianiro Fri, 08/18/2023 - 20:01 Image Copy of Untitled Design (5).png

Drug Development 40

Drug Development Drugs Marketing 40

Alta Sciences

JULY 5, 2023

How to Facilitate Your Ophthalmic Drug Development tchichekian Thu, 07/06/2023 - 01:11 HTML From Discovery to Market, We’ve Got You Covered. As a leading partner in ophthalmic drug development , Altasciences has an outstanding track record formulating, testing, and manufacturing ophthalmic products.

Drug Development 52

Drug Development Drugs Clinical Research Production 52

KIF1A

APRIL 24, 2023

KIF1A.ORG has a lot to share this month including the 2023 KAND Family & Scientific Engagement Conference registration and hotel room links! Community Highlights 2023 KAND Family & Scientific Engagement Conference!! RDDS 2023 focuses on collaboration – the foundation of success in rare disease research.

Packaging 52

Packaging Drug Development Therapies Research 52

Conversations in Drug Development Trends

OCTOBER 24, 2023

While this is a small number of people in each rare disease patient community, the significant and continued growth of rare disease drug development is unsurprising given that there are over 10,000 rare diseases , with more being discovered every year.

Clinical Trials 52

Clinical Trials Disease Therapies Drug Development 52

FDA Law Blog: Biosimilars

JUNE 27, 2023

Valentine Named Top Lawyer Under 40; Only Food and Drug Lawyer Selected Hyman, Phelps & McNamara, P.C. (HP&M) Valentine , as a 2023 Rising Star. James was only one of five life sciences attorneys selected and the only food and drug lawyer to make the list. HP&M’s Kurt R. Gibbs Paul M. Hyman Alan M. Mullen Frank J.

Science 80

Science FDA Approval FDA Drug Development 80

Alta Sciences

AUGUST 18, 2023

Symposium in Cambridge, UK—Considerations When Looking To Accelerate Your Drug Development Effectively! iianiro Fri, 08/18/2023 - 20:01 Image Copy of Untitled Design (5).png iianiro Fri, 08/18/2023 - 20:01 Image Copy of Untitled Design (5).png

Drug Development 40

Drug Development Drugs Marketing 40

Alta Sciences

JULY 20, 2023

A Proactive Drug Development Solution for Your Biologics nbartlett Thu, 07/20/2023 - 15:37 HTML The process of biologic drug development, from lead molecule identification to approval, can be long and complicated. Altasciences is here to help streamline the process.

Drug Development 40

Drug Development Biosimilars Drugs Therapies 40

Alta Sciences

JUNE 9, 2023

Accelerating Global Drug Development Timelines With Ethnobridging rmaloney Mon, 06/12/2023 - 16:07 HTML Safe Strategy to Save Time and Money Avoid repeating Phase I studies for drugs intended for the Asian market. Image Social media_e-bulletin Ethnobridging.jpg Tags Clinical Trials Weight 1

Drug Development 40

Drug Development Clinical Trials Biosimilars Pharmacokinetics 40

Conversations in Drug Development Trends

AUGUST 10, 2023

With so many exciting developments in the last few years, it’s critical for the psychedelic community to come together to reflect on our progress, share the latest discoveries, and discuss the future of psychedelic research. The post 3 Key Takeaways from Psychedelic Science 2023 appeared first on Worldwide Clinical Trials.

Science 98

Science Clinical Trials Trials Clinical Research 98

Alta Sciences

DECEMBER 29, 2023

Life Science Review: Altasciences—Eliminating Operational Silos to Accelerate and Streamline Early-Phase Drug Development aasimakopoulos Fri, 12/29/2023 - 14:48 Category News Weight 5

Drug Development 40

Drug Development Science Drugs 40

Alta Sciences

AUGUST 3, 2023

Pharma Tech Outlook: Altasciences—The Driver of Speed and Efficiency in Drug Development aasimakopoulos Thu, 08/03/2023 - 14:21 Synopsis Altasciences is named a Top Contract Manufacturing Organization of 2023 by Pharma Tech Outlook! Read the interview with Ben Reed, Executive General Manager, CDMO Category News Weight 3

Drug Development 40

Drug Development Drugs 40

Alta Sciences

MAY 15, 2023

TOP 5 WAYS INTEGRATED DRUG DEVELOPMENT SOLUTIONS SAVE YOU TIME AND MONEY aasimakopoulos Mon, 05/15/2023 - 16:06 Since 2004, the average cost of bringing a new drug to market has increased from $800 million to about $2.6 billion , without, for the most part, shorter development timelines.

Drug Development 52

Drug Development Clinical Trials Compounding Pharmacies Laboratories 52

Metabolite Tales Blog

APRIL 10, 2024

Where data was publicly available, the routes of human metabolism for each of the drugs in this subset is listed in Table 1. It is proposed that the decreased clearance of the drug observed in patients may be due to depletion of GSH in this population [10]. Drug Metab Dispos. 2023; 51(7):873-883. 2023; 62(12):1765-1779.

Small Molecule 59

Small Molecule FDA Approval FDA Pharmacokinetics 59

Alta Sciences

OCTOBER 30, 2023

Insights Care: Chris Perkin — Fostering Innovation at the Frontier of Drug Development for a Better Tomorrow aasimakopoulos Mon, 10/30/2023 - 13:28 Category News Weight 2

Drug Development 40

Drug Development Drugs 40

Perficient: Drug Development

APRIL 22, 2024

Perficient achieved the Köerber 2023 Evolve Partner Award for New OMS Partner of the Year North America. We’re excited to share some wonderful news with you all! We see this as a shared achievement, one that wouldn’t be possible without the support of our incredible team and partner Köerber.

Marketing 98

Marketing 98

Perficient: Drug Development

JUNE 26, 2023

We’re thrilled to announce that Perficient has been recognized as a 2023 Top Workplace by the St. Congratulations to the other 2023 Top Workplaces in St. Louis Post Dispatch. This award is a proven testament that underscores our ongoing commitment to fostering an exceptional work environment for our colleagues.

Research 97

Research 97

Perficient: Drug Development

OCTOBER 2, 2023

Optimizely’s Opticon 2023 begins next week on Tuesday, October 10 in sunny San Diego. Opticon 2023 Agenda Highlights Opticon Opening Keynote with Zoom Optimizely CEO Alex Atzberger and Chief Product Officer Rupali Jain will guide attendees through the Optimizely roadmap and showcase the latest product developments.

Science 59

Science Production 59

The Premier Consulting Blog

JUNE 18, 2023

This has opened new opportunities in pharmaceutical drug development, such as the ability to evaluate large complex databases and to integrate information in useful ways. One exciting application of these technologies is the use of in silico trials in the development of novel therapies for rare diseases.

Drug Development 52

Drug Development Disease Clinical Trials Drugs 52

Perficient: Drug Development

NOVEMBER 29, 2023

As you can gather from the above, MWC 2023 provided valuable insights into the latest trends and innovations in the CMT industry. If you’re interested in diving deeper into the above takeaways from MWC 2023 or would like to understand how our CMT industry expertise can benefit your business, contact us today.

Marketing 52

Marketing 52

Perficient: Drug Development

SEPTEMBER 27, 2023

The conference will take place on November 14-17, 2023, in Seattle, Washington. Microsoft Ignite is only a few weeks away! Still not registered? Click here !

52

52

Perficient: Drug Development

AUGUST 4, 2023

The Digital Transformation Services Landscape, Q3 2023 Report The recently published Forrester report defines digital transformation services as “Service providers that enable companies to leverage modern technology, practices, and ecosystems to deliver new sources of value and continuously improve business outcomes.”

Marketing 98

Marketing Research Production 98

Perficient: Drug Development

SEPTEMBER 19, 2023

What Matters Most to Insurers in 2023? DISCOVER MORE: Digital Experience Platform (DXP) – Strategy, Development, and Design ITC 2023 Agenda Sessions Topping Our Must-See List ITC’s speaker list is a who’s-who in the industry with representation from industry power houses to market disruptor technology firms.

Marketing 52

Marketing Science Production 52

Advarra

AUGUST 10, 2023

Given the relatively small populations affected by any one rare disease or condition, a pharmaceutical company developing an orphan drug may reasonably expect the final approved drug to generate relatively small sales (when compared with the drug development costs) and consequently incur a financial loss.

Drug Development 52

Drug Development Disease Therapies Engineering 52